August 1, 2026

The 99th Anniversary of the Founding of the Chinese People's Liberation Army

On this day, when military flags fly high and glory shines bright, EFUNG Capital extends its highest respect to all servicemen and women who have once donned military uniforms and defended our homeland, as well as to their families.

"A strong country must have a strong military, and only a strong military can ensure national security." Having weathered nearly a century of trials, the People's Army has advanced under the banner of the Party, forging an unbreakable iron bastion. For an investment institution with the mission of "striving for the life sciences," this ironclad faith, discipline, and sense of responsibility are not only the bedrock of national defense, but also the spiritual fuel that empowers us to overcome challenges and navigate market cycles in the capital markets.

Party Building Guidance: Party Branch Established on the Company Level

In 2023, the Party Branch of Shenzhen EFUNG Investment Management Enterprise (Limited Partnership) was officially established, marking a critical step forward for EFUNG Capital in political leadership and organizational development. Just as "establishing Party branches at the company level" in the military ensures the Party's absolute leadership over the armed forces, EFUNG firmly believes that supporting Party building is the guarantee of maintaining the right corporate direction and aligning the thinking of all employees.

In the "tough battle" of investment—a battle without gunpowder—the Party Branch of EFUNG Capital fully plays its role as a combat fortress. We understand deeply that investing in biopharmaceuticals is investing in national welfare and safeguarding public health. Only by staying committed to the philosophy of "being entrepreneur-centered and value-creator-focused" can we maintain our composure in a volatile market and translate the Party's innovative theories into a powerful driving force for arming our minds, guiding our practice, and advancing our business.

Eternal Military Spirit: Taking a Stand in the "Bottleneck" Battlefield

Looking back at the history of the People's Army, the courage to fight and the determination to win have always been defining characteristics. For EFUNG, our "battlefield" is the fierce global competition in biopharmaceuticals and the fight to overcome challenges in core technologies and innovative drugs.

Since our inception, the EFUNG team has adhered to the strategy of "investing early, investing small, and investing in hard technologies," making deep investments in over 130 high-quality domestic and international enterprises, including Chipscreen Biosciences, Frontier Biotechnologies, and Ascentage Pharma. This journey has not been smooth—much like the Army's long march through wind and rain. Our team draws inspiration from the military's indomitable spirit of "building roads through mountains and bridging rivers." We maintain patience and resilience through the long cycles of innovative drug development and have the courage to invest counter-cyclically during industry downturns. This is our responsibility to our investors—and our commitment to the future of China's biopharmaceutical industry.

Deep Bonds Between Military and Civilians: Safeguarding Public Health

The fundamental purpose of the People's Army is to serve the people wholeheartedly. As the "people's troops" of the financial sector, EFUNG Capital has always shouldered its social responsibilities. Whether it is driving the commercialization of biotech innovations through capital, or championing the values of diligence, thrift, and dedication in our daily work, the people of EFUNG are consistently guided by a deep commitment to public welfare.

History flows ceaselessly, and spirits are passed down through generations. The best tribute we can pay to the 99th anniversary of the founding of the PLA is to carry forward the glorious tradition of "obeying the Party's command, winning battles, and maintaining excellent conduct," and to achieve new milestones on the investment front. Looking ahead, EFUNG Capital will channel even greater morale and a more pragmatic approach to contribute our "EFUNG strength" to the independent development and high-quality growth of China's biopharmaceutical industry.

Salute to the Chinese Military!

1921–2026

END